FDA’s supplement import alert now covers more hidden drug ingredients
The July update reaches products sold for sexual enhancement, weight loss and muscle building—including formulas that may never make their real contents obvious.

Original image by Anecdotal
The FDA’s 9 July import alert allows listed products marketed as foods or supplements to be detained without physical examination when they contain undeclared active pharmaceutical ingredients.
Why this matters
The risk is not only that a claim is exaggerated. Some products sold as supplements can contain drug ingredients that are absent from the label, changing interaction and dosing risk.
What the alert covers
FDA investigations and laboratory analyses have identified products marketed as dietary supplements that contain undeclared pharmaceutical ingredients. The alert describes examples including anticoagulants, anticonvulsants and cholesterol-lowering drugs, alongside products promoted for weight loss, sexual enhancement and muscle building.
Products can be detained at the border when they meet the alert’s criteria. The live FDA record contains the affected firms and products; that operational list is more useful than a static reproduction.
Why labels cannot answer every safety question
An undeclared ingredient creates a different problem from a weak evidence claim. Consumers and clinicians cannot account for interactions or exposure if the active substance is missing from the label.
Anecdotal treats these notices as safety updates, not as general judgments about every product in the same category. The relevant questions are the named product, manufacturer, ingredient finding and current regulatory action.
What this is based on
The alert is operational guidance for FDA field staff and should be read with its live product list.
Regulatory action · Independent
Sources
Go straight to the source.
- 01Import Alert 54-16regulator
US Food and Drug Administration · 2026-07-09
Stay in the loop.
The safety & regulation stories worth opening, in one weekly email.
We never sell or share your email. Unsubscribe in one click.
Keep reading
More like this.

The moringa outbreak is over. The recalled powder may still be in cupboards.
The investigation closed at 131 reported cases across 38 states. Because the products last for years, that is not the same as the risk disappearing overnight.

FDA found undeclared stimulants in two Addall supplements
Testing found DMAA, DMHA and phenibut. Only one product was voluntarily recalled, which leaves an uncomfortable gap between finding and removal.

What the UK’s new supplement guidance changes for shoppers
The June update covers authorised claims, interactions and the line supplement labels cannot cross when they talk about symptoms.